FHT-CT4

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameFHT-CT4
Drug Alias NameCTLA4-PTD fusion protein (Forhumantech)FHT-CT4
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionEarly activation antigen CD69 modulators
TargetsEarly activation antigen CD69
Therapy Area/IndicationsRejection of organ transplantationInflammationAutoimmune Diseases +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesForhumantech
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesForhumantechDaewon Pharmaceutical Co Ltd
Active IndicationsN/A
Inactive IndicationsRejection of organ transplantationInflammationAutoimmune Diseases +[5] 

Other Information

ATC CodeN/A
Related LinksN/A